DNAJB9 Inhibits p53-Dependent Oncogene-Induced Senescence and Induces Cell Transformation |
Lee, Hyeon Ju
(Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine)
Jung, Yu-Jin (Department of Biological Sciences, Kangwon National University) Lee, Seungkoo (Department of Anatomic Pathology, Kangwon National University School of Medicine, Kangwon National University Hospital) Kim, Jong-Il (Genomic Medicine Institute, Medical Research Center, Seoul National University) Han, Jeong A. (Department of Biochemistry and Molecular Biology, Kangwon National University School of Medicine) |
1 | Kim, S.R., Park, J.H., Lee, M.E., Park, J.S., Park, S.C., and Han, J.A. (2008). Selective COX-2 inhibitors modulate cellular senescence in human dermal fibroblasts in a catalytic activity-independent manner. Mech. Ageing Dev. 129, 706-713. DOI |
2 | Kuk, M.U., Kim, J.W., Lee, Y.S., Cho, K.A., Park, J.T., and Park, S.C. (2019). Alleviation of senescence via ATM inhibition in accelerated aging models. Mol. Cells 42, 210-217. DOI |
3 | Kurisu, J., Honma, A., Miyajima, H., Kondo, S., Okumura, M., and Imaizumi, K. (2003). MDG1/ERdj4, an ER-resident DnaJ family member, suppresses cell death induced by ER stress. Genes Cells 8, 189-202. DOI |
4 | Lee, H.J., Kim, J.M., Kim, K.H., Heo, J.I., Kwak, S.J., and Han, J.A. (2015). Genotoxic stress/p53-induced DNAJB9 inhibits the pro-apoptotic function of p53. Cell Death Differ. 22, 86-95. DOI |
5 | Nardella, C., Clohessy, J.G., Alimonti, A., and Pandolfi, P.P. (2011). Prosenescence therapy for cancer treatment. Nat. Rev. Cancer 11, 503-511. DOI |
6 | Narita, M., Nunez, S., Heard, E., Narita, M., Lin, A.W., Hearn, S.A., Spector, D.L., Hannon, G.J., and Lowe, S.W. (2003). Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716. DOI |
7 | Ory, D.S., Neugeboren, B.A., and Mulligan, R.C. (1996). A stable humanderived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. U. S. A. 93, 11400-11406. DOI |
8 | Qiu, X.B., Shao, Y.M., Miao, S., and Wang, L. (2006). The diversity of the DnaJ/Hsp40 family, the crucial partners for Hsp70 chaperones. Cell. Mol. Life Sci. 63, 2560-2570. DOI |
9 | Sarkisian, C.J., Keister, B.A., Stairs, D.B., Boxer, R.B., Moody, S.E., and Chodosh, L.A. (2007). Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat. Cell Biol. 9, 493-505. DOI |
10 | Bartkova, J., Horejsi, Z., Koed, K., Kramer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J.M., Lukas, C., et al. (2005). DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864-870. DOI |
11 | Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.V., Kolettas, E., Niforou, K., Zoumpourlis, V.C., et al. (2006). Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633-637. DOI |
12 | Benanti, J.A. and Galloway, D.A. (2004). Normal human fibroblasts are resistant to RAS-induced senescence. Mol. Cell. Biol. 24, 2842-2852. DOI |
13 | Campisi, J. and d'Adda di Fagagna, F. (2007). Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8, 729-740. DOI |
14 | Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre, M., Nuciforo, P.G., Bensimon, A., et al. (2006). Oncogeneinduced senescence is a DNA damage response triggered by DNA hyperreplication. Nature 444, 638-642. DOI |
15 | Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404. DOI |
16 | Choi, E.M., Kim, S.R., Lee, E.J., and Han, J.A. (2009). Cyclooxygenase-2 functionally inactivates p53 through a physical interaction with p53. Biochim. Biophys. Acta 1793, 1354-1365. DOI |
17 | Courtois-Cox, S., Jones, S.L., and Cichowski, K. (2008). Many roads lead to oncogene-induced senescence. Oncogene 27, 2801-2809. DOI |
18 | Di Micco, R., Fumagalli, M., and d'Adda di Fagagna, F. (2007). Breaking news: high-speed race ends in arrest--how oncogenes induce senescence. Trends Cell Biol. 17, 529-536. DOI |
19 | Akagi, T. (2004). Oncogenic transformation of human cells: shortcomings of rodent model systems. Trends Mol. Med. 10, 542-548. DOI |
20 | Ahn, B.Y., Trinh, D.L., Zajchowski, L.D., Lee, B., Elwi, A.N., and Kim, S.W. (2010). Tid1 is a new regulator of p53 mitochondrial translocation and apoptosis in cancer. Oncogene 29, 1155-1166. DOI |
21 | Awe, K., Lambert, C., and Prange, R. (2008). Mammalian BiP controls posttranslational ER translocation of the hepatitis B virus large envelope protein. FEBS lett. 582, 3179-3184. DOI |
22 | Trinh, D.L., Elwi, A.N., and Kim, S.W. (2010). Direct interaction between p53 and Tid1 proteins affects p53 mitochondrial localization and apoptosis. Oncotarget 1, 396-404. DOI |
23 | Serrano, M., Lin, A.W., McCurrach, M.E., Beach, D., and Lowe, S.W. (1997). Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602. DOI |
24 | Shen, Y., Meunier, L., and Hendershot, L.M. (2002). Identification and characterization of a novel endoplasmic reticulum (ER) DnaJ homologue, which stimulates ATPase activity of BiP in vitro and is induced by ER stress. J. Biol. Chem. 277, 15947-15956. DOI |
25 | Tomayko, M.M. and Reynolds, C.P. (1989). Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother. Pharmacol. 24, 148-154. DOI |
26 | Vos, M.J., Hageman, J., Carra, S., and Kampinga, H.H. (2008). Structural and functional diversities between members of the human HSPB, HSPH, HSPA, and DNAJ chaperone families. Biochemistry 47, 7001-7011. DOI |
27 | Walsh, P., Bursac, D., Law, Y.C., Cyr, D., and Lithgow, T. (2004). The J-protein family: modulating protein assembly, disassembly and translocation. EMBO Rep. 5, 567-571. DOI |
28 | Zhao, J.J., Roberts, T.M., and Hahn, W.C. (2004). Functional genetics and experimental models of human cancer. Trends Mol. Med. 10, 344-350. DOI |
29 | Ferbeyre, G., de Stanchina, E., Lin, A.W., Querido, E., McCurrach, M.E., Hannon, G.J., and Lowe, S.W. (2002). Oncogenic ras and p53 cooperate to induce cellular senescence. Mol. Cell. Biol. 22, 3497-3508. DOI |
30 | Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E.E., Linskens, M., Rubelj, I., Pereira-Smith, O., et al. (1995). A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92, 9363-9367. DOI |
31 | Gao, J., Aksoy, B.A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S.O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013). Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1. |
32 | Halazonetis, T.D., Gorgoulis, V.G., and Bartek, J. (2008). An oncogeneinduced DNA damage model for cancer development. Science 319, 1352-1355. DOI |
33 | Hanahan, D. and Weinberg, R.A. (2000). The hallmarks of cancer. Cell 100, 57-70. DOI |
34 | Kang, T.W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011). Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551. DOI |
35 | Hanahan, D. and Weinberg, R.A. (2011). Hallmarks of cancer: the next generation. Cell 144, 646-674. DOI |
36 | Hartl, F.U., Bracher, A., and Hayer-Hartl, M. (2011). Molecular chaperones in protein folding and proteostasis. Nature 475, 324-332. DOI |
37 | Jozefczuk, J., Drews, K., and Adjaye, J. (2012). Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells. J. Vis. Exp. 64, 3854. |